In particular, CITED2 is suspected to be extensively involved in prostate cancer, since its expression is induced by an ETS family member ELK119, which has been reported to recruit AR to activate growth signaling in prostate cancer cells20. This evidence concerns the gene AR and prostate carcinoma.